Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Seagen Inc. | ex-3212020q1.htm |
| EX-31.2 - EXHIBIT 31.2 - Seagen Inc. | ex-3122020q1.htm |
| EX-31.1 - EXHIBIT 31.1 - Seagen Inc. | ex-3112020q1.htm |
| EX-10.4 - EXHIBIT 10.4 - Seagen Inc. | ex-1042020q1.htm |
| EX-10.3 - EXHIBIT 10.3 - Seagen Inc. | ex-1032020q1.htm |
| EX-10.2 - EXHIBIT 10.2 - Seagen Inc. | ex-1022020q1.htm |
| EX-10.1 - EXHIBIT 10.1 - Seagen Inc. | ex-1012020q1.htm |
| 10-Q - 10-Q - Seagen Inc. | a10q2020q1.htm |
Exhibit 32.2
SEATTLE GENETICS, INC.
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Seattle Genetics, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Todd E. Simpson, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
By: | /s/ Todd E. Simpson |
Todd E. Simpson | |
Chief Financial Officer | |
(Principal Financial and Accounting Officer) | |
Date: | April 30, 2020 |
This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Seattle Genetics, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.